Most bought healthcare stocks in Q1 2024
See which Healthcare stocks institutional investors increased the most in Q1 2024, measured as net growth in reported share positions from Q4 2023 into Q1 2024. Notable additions at the top of this list include STANDARD BIOTOOLS INC (LAB), HALEON PLC-ADR (HLN), CVS HEALTH CORP (CVS), BRISTOL-MYERS SQUIBB CO (BMY). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| LAB | STANDARD BIOTOOLS INC | 71,907,868 | $194.29M | 2 | 1 | 0 | 0 | 3 |
| HLN | HALEON PLC-ADR | 64,776,937 | $592.10M | 0 | 3 | 5 | 1 | 8 |
| CVS | CVS HEALTH CORP | 15,619,321 | $1.32B | 3 | 5 | 12 | 3 | 21 |
| BMY | BRISTOL-MYERS SQUIBB CO | 5,514,784 | $511.38M | 3 | 8 | 7 | 4 | 19 |
| GEHC | GE HEALTHCARE TECHNOLOGY | 5,269,791 | $771.68M | 3 | 5 | 4 | 1 | 16 |
| AVTR | AVANTOR INC | 5,097,260 | $325.26M | 3 | 2 | 2 | 1 | 10 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 5,012,517 | $793.95M | 1 | 3 | 9 | 0 | 14 |
| ZTS | ZOETIS INC | 4,611,984 | $398.35M | 4 | 5 | 7 | 1 | 17 |
| ABT | ABBOTT LABORATORIES | 4,248,840 | $462.53M | 2 | 7 | 7 | 2 | 21 |
| RXRX | RECURSION PHARMACEUTICALS-A | 3,950,248 | $41.66M | 1 | 1 | 1 | 0 | 3 |
| ORIC | ORIC PHARMACEUTICALS INC | 3,922,400 | $55.00M | 1 | 0 | 1 | 0 | 2 |
| ABSI | ABSCI CORP | 3,276,794 | $18.61M | 1 | 0 | 1 | 0 | 2 |
| PRME | PRIME MEDICINE INC | 3,164,192 | $14.15M | 0 | 2 | 0 | 0 | 2 |
| LFST | LIFESTANCE HEALTH GROUP INC | 3,018,143 | $4.40M | 1 | 1 | 0 | 0 | 2 |
| NVST | ENVISTA HOLDINGS CORP | 2,888,882 | $51.54M | 2 | 1 | 2 | 0 | 5 |
| DOCS | DOXIMITY INC-CLASS A | 2,784,328 | $66.25M | 1 | 2 | 2 | 1 | 5 |
| WBA | WALGREENS BOOTS ALLIANCE INC | 2,446,366 | $887.48K | 1 | 4 | 2 | 1 | 7 |
| BAYRY | BAYER AG-SPONSORED ADR | 2,386,640 | $17.16M | 0 | 1 | 0 | 0 | 1 |
| TXG | 10X GENOMICS INC-CLASS A | 2,327,309 | $10.86M | 2 | 2 | 1 | 0 | 5 |
| IMVT | IMMUNOVANT INC | 2,130,572 | $58.46M | 1 | 1 | 0 | 0 | 2 |
| OGN | ORGANON & CO | 1,757,042 | $54.10M | 2 | 3 | 1 | 1 | 7 |
| BSX | BOSTON SCIENTIFIC CORP | 1,710,007 | $157.69M | 2 | 2 | 6 | 0 | 11 |
| MRK | MERCK & CO. INC. | 1,585,111 | $322.58M | 4 | 6 | 15 | 2 | 28 |
| OPK | OPKO HEALTH INC | 1,378,196 | $1.65K | 1 | 0 | 0 | 0 | 1 |
| HUM | HUMANA INC | 1,374,030 | $544.80M | 4 | 3 | 3 | 1 | 10 |
| ME | 23ANDME HOLDING CO -CLASS A | 1,370,100 | -$598 | 0 | 1 | 0 | 0 | 1 |
| ADMA | ADMA BIOLOGICS INC | 1,070,384 | $808.94K | 1 | 1 | 0 | 0 | 2 |
| LBPH | LONGBOARD PHARMACEUTICALS IN | 1,052,728 | $21.20M | 2 | 0 | 0 | 0 | 2 |
| MRNA | MODERNA INC | 1,041,861 | $105.03M | 3 | 4 | 5 | 0 | 13 |
| UNH | UNITEDHEALTH GROUP INC | 1,036,252 | $152.49M | 3 | 17 | 12 | 3 | 37 |
| ACB | AURORA CANNABIS INC | 933,738 | $325.02K | 2 | 0 | 0 | 0 | 2 |
| VXRT | VAXART INC | 881,800 | $7.00K | 0 | 1 | 0 | 0 | 2 |
| FOLD | AMICUS THERAPEUTICS INC | 878,800 | $10.17K | 0 | 1 | 0 | 0 | 1 |
| COO | COOPER COS INC/THE | 852,230 | $72.38M | 4 | 0 | 0 | 0 | 4 |
| IKNA | IKENA ONCOLOGY INC | 776,600 | $1.10K | 1 | 0 | 0 | 0 | 1 |
| VREX | VAREX IMAGING CORP | 769,124 | $10.71M | 0 | 2 | 1 | 0 | 3 |
| ESPR | ESPERION THERAPEUTICS INC | 721,400 | $21.93K | 0 | 2 | 0 | 0 | 2 |
| DXCM | DEXCOM INC | 718,550 | $31.63M | 2 | 2 | 4 | 1 | 9 |
| IMUX | IMMUNIC INC | 672,465 | $874 | 0 | 1 | 0 | 0 | 1 |
| PGNY | PROGYNY INC | 667,502 | $23.01M | 2 | 2 | 0 | 0 | 4 |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 661,000 | $2.17M | 1 | 1 | 0 | 0 | 3 |
| CARA | CARA THERAPEUTICS INC | 638,406 | $306.01K | 0 | 2 | 0 | 0 | 2 |
| CERS | CERUS CORP | 626,070 | -$4.45M | 0 | 1 | 1 | 0 | 2 |
| FTRE | FORTREA HOLDINGS INC | 618,226 | $6.31M | 1 | 2 | 1 | 2 | 5 |
| LLY | ELI LILLY & CO | 617,280 | $1.37B | 3 | 7 | 11 | 2 | 22 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 598,903 | -$1.66M | 0 | 2 | 0 | 0 | 2 |
| VNDA | VANDA PHARMACEUTICALS INC | 594,500 | $2.04K | 0 | 1 | 0 | 0 | 1 |
| TNDM | TANDEM DIABETES CARE INC | 576,100 | $20.51K | 0 | 1 | 0 | 0 | 1 |
| CORT | CORCEPT THERAPEUTICS INC | 572,212 | $4.49M | 2 | 1 | 0 | 0 | 3 |
| CNC | CENTENE CORP | 564,424 | $63.84M | 2 | 2 | 4 | 3 | 8 |
Frequently asked questions about Most bought healthcare stocks in Q1 2024
What are the most bought Healthcare stocks in Q1 2024?
The most bought healthcare stocks in Q1 2024 are those with the largest increase in reported share counts across institutional investors compared to Q4 2023, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q1 2024?
Among filers in this sector, net additions were largest in companies such as STANDARD BIOTOOLS INC (LAB), HALEON PLC-ADR (HLN), CVS HEALTH CORP (CVS), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q4 2023).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.